Viewing nowCombinationAjushta Tablet 40/5 mg
Telmisartan Powder 23.9% 40mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Ajou Pharmaceutical Co., Ltd.

MFDS item code 201607299 · Approved 2016.12.27 · Insurance code 654004850
Treatment of essential hypertension not controlled with monotherapy
This medication is used for patients with essential hypertension who have difficulty controlling their blood pressure. Amlodipine or telmisartan monotherapy is used to help adequately lower and control blood pressure. These medications improve hypertension by expanding blood vessels or through mechanisms that regulate blood pressure. Proper blood pressure management plays a crucial role in reducing the risk of cardiovascular diseases and maintaining health. This medication is effective for controlling patients' blood pressure and is used to stabilize health status with regular use.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 mg). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients who should use this medicine with caution’). In patients 75 years of age or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication can cause serious harm to the fetus, especially during the second and third trimesters of pregnancy, so it should not be taken by pregnant women or women who may become pregnant. This medication should not be administered to patients with hypersensitivity, nursing mothers, patients with severe liver dysfunction, patients with severe cardiac disease, and patients with severe hypotension. Caution is advised for patients with decreased liver function, gastrointestinal diseases, renal dysfunction, and elderly patients when using this medication. Common side effects include dizziness or edema, and serious reactions related to the heart or kidneys may occur rarely. During pregnancy, the use of this medication can pose risks of decreased kidney function in the fetus, skull formation disorders, and hypotension in newborns, so it should be discontinued as quickly as possible. This medication may interact with other drugs, so caution is necessary, especially when co-administered with lithium, digoxin, warfarin, and non-steroidal anti-inflammatory drugs. Nursing mothers are advised not to take this medication, and women planning to conceive should switch to another safer antihypertensive medication. The safety and efficacy of this medication have not been sufficiently established in children, so it is not recommended for pediatric use. Elderly patients may be more sensitive to this medication, and treatment should start at a lower dose, with gradual adjustments. Overdosing may cause symptoms such as hypotension, dizziness, and decreased cardiac function, so immediate medical attention is required. This medication should be kept out of reach of children and should not be transferred to another container; it should be taken immediately after opening the package. When driving or operating machinery, caution is needed as dizziness or drowsiness may occur after taking this medication.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a container that protects it from light. Additionally, it is best to keep the medication at room temperature, between 1°C and 30°C, avoiding excessively hot or cold places.
This is a biconvex, oval-shaped double tablet that is white and light gray.
30 tablets (10 tablets/PTP X 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 40mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Ajou Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.